Engineered protein complex could help immunotherapies target hard-to-treat neuroblastoma
Researchers from Children's Hospital of Philadelphia (CHOP) have developed a method to help cancer immunotherapies reach otherwise "invisible" tumors by helping guide therapies to their appropriate targets. This could be ...
Jan 8, 2026
0
0









